Vincerx Graham Net Net from 2010 to 2026
| VINC Stock | USD 0.01 0.0002 1.57% |
Graham Net Net | First Reported 2010-12-31 | Previous Quarter 0.11 | Current Value 0.1 | Quarterly Volatility 10.31691501 |
Check Vincerx Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vincerx Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 8.7 M or Selling General Administrative of 13.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 9.55. Vincerx financial statements analysis is a perfect complement when working with Vincerx Pharma Valuation or Volatility modules.
Vincerx | Graham Net Net | Build AI portfolio with Vincerx Stock |
Analyzing Vincerx Pharma's Graham Net Net over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Graham Net Net has evolved provides context for assessing Vincerx Pharma's current valuation and future prospects.
Latest Vincerx Pharma's Graham Net Net Growth Pattern
Below is the plot of the Graham Net Net of Vincerx Pharma Common over the last few years. It is Vincerx Pharma's Graham Net Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vincerx Pharma's overall financial position and show how it may be relating to other accounts over time.
| Graham Net Net | 10 Years Trend |
|
Graham Net Net |
| Timeline |
Vincerx Graham Net Net Regression Statistics
| Arithmetic Mean | 4.26 | |
| Geometric Mean | 0.70 | |
| Coefficient Of Variation | 241.90 | |
| Mean Deviation | 6.33 | |
| Median | 0.45 | |
| Standard Deviation | 10.32 | |
| Sample Variance | 106.44 | |
| Range | 39.431 | |
| R-Value | 0.19 | |
| Mean Square Error | 109.37 | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | 0.39 | |
| Total Sum of Squares | 1,703 |
Vincerx Graham Net Net History
About Vincerx Pharma Financial Statements
Vincerx Pharma stakeholders use historical fundamental indicators, such as Vincerx Pharma's Graham Net Net, to determine how well the company is positioned to perform in the future. Although Vincerx Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Vincerx Pharma's assets and liabilities are reflected in the revenues and expenses on Vincerx Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Vincerx Pharma Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Graham Net Net | 0.11 | 0.10 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vincerx Pharma Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Common Stock:Check out the analysis of Vincerx Pharma Correlation against competitors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Biotechnology sector continue expanding? Could Vincerx diversify its offerings? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Vincerx Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Vincerx Pharma Common requires distinguishing between market price and book value, where the latter reflects Vincerx's accounting equity. The concept of intrinsic value - what Vincerx Pharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Vincerx Pharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vincerx Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.